MA49448A - Compositions pharmaceutiques contenant du fumarate de diméthyle - Google Patents
Compositions pharmaceutiques contenant du fumarate de diméthyleInfo
- Publication number
- MA49448A MA49448A MA049448A MA49448A MA49448A MA 49448 A MA49448 A MA 49448A MA 049448 A MA049448 A MA 049448A MA 49448 A MA49448 A MA 49448A MA 49448 A MA49448 A MA 49448A
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- dimethyl fumarate
- containing dimethyl
- fumarate
- Prior art date
Links
- LDCRTTXIJACKKU-ONEGZZNKSA-N dimethyl fumarate Chemical compound COC(=O)\C=C\C(=O)OC LDCRTTXIJACKKU-ONEGZZNKSA-N 0.000 title 1
- 229960004419 dimethyl fumarate Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1710114.8A GB201710114D0 (en) | 2017-06-23 | 2017-06-23 | Pharmaceutical compositions |
| EP17382402 | 2017-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49448A true MA49448A (fr) | 2020-04-29 |
Family
ID=62791731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049448A MA49448A (fr) | 2017-06-23 | 2018-06-25 | Compositions pharmaceutiques contenant du fumarate de diméthyle |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11602515B2 (enExample) |
| EP (1) | EP3641736A1 (enExample) |
| JP (1) | JP7308763B2 (enExample) |
| KR (1) | KR20200018458A (enExample) |
| CN (1) | CN110636838A (enExample) |
| AU (1) | AU2018287442A1 (enExample) |
| CA (1) | CA3059293A1 (enExample) |
| MA (1) | MA49448A (enExample) |
| WO (1) | WO2018234584A1 (enExample) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| DE10101307A1 (de) | 2001-01-12 | 2002-08-01 | Fumapharm Ag Muri | Fumarsäurederivate als NF-kappaB-Inhibitor |
| PL2801354T3 (pl) | 2004-10-08 | 2017-08-31 | Forward Pharma A/S | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające ester kwasu fumarowego |
| ATE461701T1 (de) | 2005-04-28 | 2010-04-15 | Wyeth Corp | Mikronisiertes tanaproget und zusammensetzungen damit |
| EP1940382A2 (en) | 2005-10-07 | 2008-07-09 | Aditech Pharma AB | Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders |
| US20080299196A1 (en) | 2005-10-07 | 2008-12-04 | Aditech Pharma Ab | Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester |
| WO2009118764A1 (en) | 2008-03-28 | 2009-10-01 | Panacea Biotec Limited | Pharmaceutical composition comprising diclofenac and paracetamol |
| US20120034274A1 (en) | 2009-01-09 | 2012-02-09 | Forward Pharma A/S | Pharmaceutical composition comprising one or more fumaric acid esters |
| RU2743637C2 (ru) | 2009-01-09 | 2021-02-20 | Фвп Ип Апс | Фармацевтический состав, содержащий один или более эфиров фумаровой кислоты в разлагаемой матрице |
| EP3318249A1 (en) | 2009-04-29 | 2018-05-09 | Biogen MA Inc. | Dimethyl fumarate dosage regimens for the treatment of multiple sclerosis |
| US20120308562A1 (en) | 2011-06-03 | 2012-12-06 | Derynck Mika K | Methods of treating mesothelioma with a pi3k inhibitor compound |
| PE20150092A1 (es) | 2012-02-07 | 2015-02-06 | Biogen Idec Inc | Composiciones farmaceuticas que contienen fumarato de dimetilo |
| SG10201913076PA (en) | 2013-12-12 | 2020-02-27 | Almirall Sa | Pharmaceutical compositions comprising dimethyl fumarate |
| MA40982A (fr) | 2014-11-19 | 2017-09-26 | Biogen Ma Inc | Formulation de bille pharmaceutique comprenant du fumarate de diméthyle |
-
2018
- 2018-06-25 KR KR1020197037153A patent/KR20200018458A/ko not_active Ceased
- 2018-06-25 US US16/625,092 patent/US11602515B2/en active Active
- 2018-06-25 CA CA3059293A patent/CA3059293A1/en active Pending
- 2018-06-25 CN CN201880032458.1A patent/CN110636838A/zh active Pending
- 2018-06-25 AU AU2018287442A patent/AU2018287442A1/en not_active Abandoned
- 2018-06-25 MA MA049448A patent/MA49448A/fr unknown
- 2018-06-25 WO PCT/EP2018/066970 patent/WO2018234584A1/en not_active Ceased
- 2018-06-25 JP JP2019570520A patent/JP7308763B2/ja active Active
- 2018-06-25 EP EP18735535.9A patent/EP3641736A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020524685A (ja) | 2020-08-20 |
| KR20200018458A (ko) | 2020-02-19 |
| AU2018287442A1 (en) | 2019-11-07 |
| CN110636838A (zh) | 2019-12-31 |
| JP7308763B2 (ja) | 2023-07-14 |
| WO2018234584A1 (en) | 2018-12-27 |
| EP3641736A1 (en) | 2020-04-29 |
| CA3059293A1 (en) | 2018-12-27 |
| US11602515B2 (en) | 2023-03-14 |
| US20200197348A1 (en) | 2020-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3565550A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH MELOXICAM | |
| EP3621621A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH MELOXICAM | |
| EP3256138A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH MELOXICAM | |
| EP3615040C0 (en) | HAIR TREATMENT COMPOSITIONS | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| IL257531A (en) | Therapeutic combinations comprising anti-folr1 immunoconjugates | |
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| EP2811994A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH DIMETHYLFUMARATE | |
| EP3515467C0 (en) | OPHTHALMIC COMPOSITION COMPRISING CICLOSPORINE | |
| DK3655017T3 (da) | Farmaceutisk sammensætning | |
| EP3641771A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| PT3500255T (pt) | Composições farmacêuticas oftálmicas e utilizações relacionadas com estas | |
| EP3415008A4 (en) | GERMIC COMPOSITION | |
| DK3709978T3 (da) | Farmaceutisk oral formulering omfattende bakterier | |
| MA49947A (fr) | Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| EP3610851A4 (en) | COMPOSITION OF SKIN CLEANSING AGENT | |
| EP3429589A4 (en) | PHARMACEUTICAL COMPOSITION OF NILOTINIB | |
| DK3583943T3 (da) | Farmaceutisk sammensætning | |
| MA49837A (fr) | Compositions pharmaceutiques | |
| EP3610848A4 (en) | COMPOSITION OF SKIN CLEANSING AGENT | |
| SMT202400478T1 (it) | Composizione farmaceutica | |
| EP3646863A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3826606A4 (en) | Liquid fragrance compositions | |
| EP3610847A4 (en) | COMPOSITION OF SKIN CLEANSING AGENT |